AXSM Next Earnings Date Notes

— Axsome Therapeutics (AXSM) is a biopharmaceutical company focused on developing&commercializing therapies for central nervous system (CNS) disorders, including depression, migraine, & narcolepsy. Their lead product, Auvelity, is an FDA-approved, fast-acting oral treatment for major depressive disorder (MDD), while their pipeline includes Sunosi (for excessive daytime sleepiness), AXS-07 (for migraine), and several early-stage candidates. For long-term performance, investors should pay close attention to Auvelity's prescription growth & net product revenue, Sunosi's market expansion since Axsome acquired it, progress of late-stage pipeline assets (notably new indications or pivotal trial readouts), & the company’s cash position relative to R&D/investment needs. Metrics such as quarterly sales trends, patient retention rates, regulatory milestones, and updates on payer coverage/reimbursement are highly relevant. Investors should listen for commentary on Auvelity's competitive positioning, commercial strategies, formulary wins, and ongoing clinical trial timelines. Monitoring these key business drivers will provide the clearest insight into Axsome Therapeutics’ trajectory and ability to achieve sustainable growth in the CNS therapeutics market. The next confirmed earnings date for AXSM is 11/2/2026 7:00 am.

AXSM Next Earnings Date FAQ

On this page we presented the AXSM Next Earnings Date information for Axsome Therapeutics along with recent past earnings dates. For Q2 of 2026, AXSM reported earnings of -0.990/share, with the earnings report taking place on 8/10/2026. For Q1 of 2026, AXSM reported earnings of -1.260/share, with the earnings report taking place on 5/4/2026. For Q4 of 2025, AXSM reported earnings of -0.560/share, with the earnings report taking place on 2/23/2026. For Q3 of 2025, AXSM reported earnings of -0.680/share, with the earnings report taking place on 11/3/2025. For Q2 of 2025, AXSM reported earnings of -0.470/share, with the earnings report taking place on 8/4/2025. And with these past earnings dates behind AXSM, investors can look ahead to the next confirmed earnings date of 11/2/2026 7:00 am.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Axsome Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Axsome Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Axsome Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next AXSM earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up AXSM's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the AXSM next earnings date.